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Abstract 
Pseudomonas aeruginosa is an important opportunistic pathogen, especially in the context of 
infections of cystic fibrosis (CF). In order to facilitate coordinated study of this pathogen, an 
international reference panel of P. aeruginosa isolates was assembled. Here we report the 
genome sequencing and analysis of 33 of these isolates and 7 reference genomes to further 
characterise this panel. Core genome single nucleotide variant phylogeny demonstrated that 
the panel strains are widely distributed amongst the P. aeruginosa population. Common loss 
of function mutations reported as adaptive during CF (such as in mucA and mexA) were 
identified amongst isolates from chronic respiratory infections. From the 40 strains analysed, 
37 unique resistomes were predicted, based on the Resistance Gene Identifier method using 
the Comprehensive Antibiotic Resistance Database. Notably, hierarchical clustering and 
phylogenetic reconstructions based on the presence/absence of genomic islands (GIs), 
prophages and other Regions of Genome Plasticity (RGPs) supported the subdivision of P. 
aeruginosa into two main groups. This is the largest, most diverse analysis of GIs and 
associated RGPs to date, and the results suggest that, at least at the largest clade grouping 
level (Group 1 vs Group 2), each group may be drawing upon distinct mobile gene pools. 
 
Introduction 
Pseudomonas aeruginosa is a leading cause of nosocomial and other opportunistic infections, 
especially in relation to chronic lung infections of patients with the genetically inherited 
disease cystic fibrosis (CF) (Lyczak et al., 2000, Cohen & Prince, 2012).  Increasingly, it is 
associated with high levels of multidrug resistance, with important clinical and economic 
consequences (Nathwani et al., 2014).  Indeed, P. aeruginosa has been included in the group 
of bacteria (the ESKAPE pathogens) most associated with the worrying increases in 
antimicrobial resistance (Pendleton et al., 2013) and has been identified by the World Health 
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Organisation as one of the top three priority pathogens urgently requiring new antimicrobial 
therapies for treatment. 
Much of the research carried out into the mechanisms of virulence of P. aeruginosa 
has been focused on a limited number of strains, most notably strain PAO1, which many 
consider to be a laboratory strain, and which has itself diversified during its existence in 
multiple laboratories (Stover et al., 2000, Klockgether et al., 2010).  Taking into account the 
diversity in phenotypic behaviour and population structure within the species (Freschi et al., 
2015), and the desirability of using relevant clinical isolates, a strain panel of diverse P. 
aeruginosa strains was assembled (De Soyza et al., 2013).  The panel was chosen to represent 
diversity in source (clinical, environmental, and geographical) and phenotype.  Subsequently, 
detailed phenotypic characterisation was carried out in order to clearly define the 
characteristics of the panel strains (Cullen et al., 2015). 
The global P. aeruginosa population is highly diverse, but also contains some 
abundant clones, such as the PA14-like lineage and Clone C (Cramer et al., 2012, Hilker et 
al., 2015).  Since the publication of the first complete P. aeruginosa genome sequence in 
2000 (Stover et al., 2000) there has been considerable progress with the comparative 
genomics of the species, with a number of studies reporting analyses of multiple genomes 
(Mathee et al., 2008, Jeukens et al., 2014, Stewart et al., 2014, Kos et al., 2015, van Belkum 
et al., 2015).  Other studies have focused on genomic variations within individual lineages 
(Williams et al., 2015, Fischer et al., 2016).  As well as helping us to resolve the phylogeny 
of P. aeruginosa, these studies have revealed key genomic features that vary between strains 
and contribute to the diversity of the species, including the island and prophages that 
dominate the accessory genome (Pohl et al., 2014). 
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Adaptation and phenotypic diversification are key features of long-term chronic lung 
infections in CF patients (Winstanley et al., 2016), emphasising the difficulty in inferring 
mechanisms of behaviour during infection on the basis of single isolates or strains.  Hence, it 
is important to access a diverse panel of P. aeruginosa strains that can better represent the 
diversity.  The International Pseudomonas aeruginosa Consortium was formed with the aim 
of genome sequencing >1000 P. aeruginosa genomes and constructing an analysis pipeline 
for the study of P. aeruginosa evolution, virulence and antibiotic resistance (Freschi et al., 
2015).  Here, as part of this larger endeavour, in order to better define the characteristics of 
the international P. aeruginosa reference panel of strains, we present comparative genomics 
analyses based on whole genome sequence data. 
 
Methods 
Bacterial strains and growth conditions 
The isolates used in this study are listed in Table 1.  Bacterial colonies were isolated on 
DifcoTM Pseudomonas Isolation Agar (BD, Sparks MD, USA). Strain NN1 from the original 
panel was omitted from this study because of contamination issues. Strains AA43 and AA44 
were omitted at the request of the original suppliers of these isolates. 
DNA extraction, library prep and genome sequencing  
Genomic DNA was extracted from overnight cultures using the DNeasy Blood and Tissue 
Kit (QIAGEN, Hilden, Germany). Genomic DNA (500 ng) was mechanically fragmented for 
40 s using a Covaris M220 (Covaris, Woburn MA, USA) with default settings. Fragmented 
DNA was transferred to a tube and library synthesis was performed with the Kapa Hyperprep 
kit (Kapa Biosystems, Wilmington MA, USA) according to manufacturer‟s instructions. 
TruSeq HT adapters (Illumina, SanDiego CA, USA) were used to barcode the libraries, 
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which were each sequenced in 1/48 of an Illumina MiSeq 300 bp paired-end run at the 
Plateforme d‟Analyses Génomiques of the Institut de Biologie Intégrative et des Systèmes 
(Laval University, Quebec, Canada). Each dataset was assembled de novo with the A5 
pipeline version A5-miseq 20140521 (Tritt et al., 2012).  Where necessary, we resequenced 
some strains for which genome sequence data was already available.  This was done to ensure 
uniform, higher quality genomes across the panel. 
 
Core genome phylogeny  
We performed a core genome phylogeny using the Harvest suite version v1.1.2 (Treangen et 
al., 2014).  In addition to the panel strains, we included all strains present on NCBI for which 
an assembly with less than 30 scaffolds was available on November 2015. 
 
Variant calling 
For 38 panel strains (for which high quality short read data were available), sequence reads 
were mapped to the genome of P. aeruginosa (PAO1) using the Burroes-Wheeler Alignment 
(bwa) tool (v0.7.5a; bwa-mem) (Li & Durbin, 2009) with standard parameters. The reference 
genome (fasta) was first indexed with bwa index (Li & Durbin, 2009) and samtools (Li et al., 
2009) faidx. A sequence dictionary was created using picard-tools  
(http://broadinstitute.github.io/picard/; v1.135) CreateSequenceDictionary. The resulting 
sequence alignment map (sam) file from read mapping with bwa-mem was converted to a 
binary alignment map (bam) file using picard-tools SortSam and duplicates were marked 
using picard-tools MarkDuplicates.  Finally a bam file index was created with picard-tools 
BuildBamIndex. The Genome Analysis Toolkit (GATK) (McKenna et al., 2010) (v3.4.) 
Realignor Target Creator was used to designate targets for indel realignment and indels were 
realigned with GATK IndelRealigner. Variants were called using GATK HaplotypeCaller (-
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ploidy 1, –emitRefConfidence, GVCF) to produce a variant call file (vcf) that was genotyped 
using GATK  GenotypeGVCFs and filtered using vcf tools (Danecek et al., 2011) vcffilter 
basic filtering (DP >9 and QUAL >10). Variant annotation was performed using snpEff 
(v4.1) (Cingolani et al., 2012) with the default parameters for gatk output (eff -gatk) to the 
reference genome database for PAO1 (uid57945). In addition, we evaluated whether a gene 
has a larger deletion not reported due to lack of sequencing reads for GATK or absence of 
genomic context in vcf files when predicting impact. First bam files were indexed with 
samtools index and the reads were aligned to a specified region (in this case a gene matching 
the coordinates in the snpEff database) using samtools depth. The results were processed to 
get an approximate „alignment‟ length from which larger deletions could be determined. 
Deletions smaller than 30 bp were checked by aligning the reference gene with blastn (v 
2.2.27+) (Camacho et al., 2009) to the assembled genome.  
 
Resistome analysis 
Antimicrobial resistance (AMR) genes were identified in all genomes based on the 
Comprehensive Antibiotic Resistance Database (CARD) (McArthur et al., 2013).  This was 
done using the command-line version of the Resistance Gene Identifier (RGI) software, 
version 3.0.1 (McArthur et al., 2013). This software is based on BLASTP searches against 
the CARD, with curated e-value cut-offs to determine the presence of AMR genes, plus 
additional variant analysis. 
Regions of genome plasticity, genomic islands and prophages 
To identify Regions of Genome Plasticity (RGPs), groups of orthologous proteins were 
computed using OrthoFinder v0.4 (Emms & Kelly, 2015), resulting in 8819 orthogroups, out 
of which 1211 contained singletons. For draft genomes, contigs were reordered by similarity 
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to a reference genome, as stated in Supplementary Table 1, using IslandViewer 3 (Dhillon et 
al., 2015) to obtain a pseudochromosome. For each genome/pseudochromosome, an RGP 
was defined as a genomic region with at least two consecutive predicted coding sequences 
(CDS) conserved in 36 genomes compared or less. One conserved gene was allowed if 
surrounded by other CDS fulfilling the criteria, since transposable elements, often present in 
multiple copies and conserved across the strains, may otherwise be incorrectly split larger 
regions into smaller segments. The conserved CDS upstream and downstream of each RGP 
serving as genomic anchors and possible insertion sites were retrieved and their orthogroup 
was used to identify hotspots of RGPs along the PAO1 genome.  Nucleotide sequence 
similarity between RGPs was scored using Mash (Ondov et al., 2016) and RGPs closer than a 
Mash distance of 0.04 were used to reconstruct groups of similar RGPs. Additional manual 
curation was performed in Cytoscape v3.4.0 (Shannon et al., 2003) to remove edges linking 
larger interconnected groups and a between-edge clustering was performed in R v3.3.3. To 
validate our findings, RGPs were compared to a manually curated dataset based on previous 
analyses and literature review for PAO1 (Mathee et al., 2008). Genomic islands (GIs; clusters 
of genes of probable horizontal origin usually identified with cutoffs larger than for RGPs) 
were predicted using the comparative genomics approach of IslandPick (Langille et al., 
2008), plus the sequence composition-based approaches SIGI-HMM (Waack et al., 2006) and 
IslandPath-DIMOB v1.0.0 (Bertelli & Brinkman, 2018), as available in IslandViewer 4 
(Bertelli et al., 2017). Prophages were predicted using PHASTER (Arndt et al., 2016). All 
RGPs were further classified as GIs or prophage when overlapping their respective 
predictions. Further data processing was performed in R using packages GenomicRanges, 
igraph, plotrix, ape, phangorn, and vegan.  The circular plot was produced using CIRCOS 
(Krzywinski et al., 2009). 
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Results and Discussion  
Distribution of the panel strain genomes amongst the wider P. aeruginosa population  
Using core genome Single Nucleotide Variant (SNV) phylogeny analysis of the panel strains 
alongside genome sequence data from strains publicly available on NCBI, we were able to 
place the panel strains in the wider context of the P. aeruginosa population (Figure 1).  The 
panel strains were widely distributed, with 31 strains in group 1 and 9 strains in group 2 
(Figure 1 and Table 1).        
Loss of function mutations in panel strain genomes 
The panel strain genomes were analysed for the presence of likely loss of function mutations 
that may be associated with known phenotypes.  In particular, we focused on mutations that 
have been linked to adaptation during chronic infections of CF patients (summarised in Table 
2).  Several panel strains contain putative loss of function mutations in the gene encoding the 
virulence-related quorum sensing regulator LasR, reported as a common adaptation in CF.  
They include five CF isolates, including representatives of four transmissible strains 
(LES400, AMT0023-34, AUS23, AUS52, KK1 and DK2).  However, severe lasR mutations 
were also identified in the community acquired pneumonia isolate A5803, the burn-related 
isolate Mi162 and the tobacco plant isolate CPHL9433, indicating that such mutations are not 
restricted to CF.  In a previous study (Cullen et al., 2015), these isolates were tested for 
pyocyanin production.  Whilst the strains LES400, AMT0023-34, AUS23, AUS52, KK1, 
DK2 and Mi162 were amongst the low producers of pyocyanin, despite its lasR mutation 
strain CPHL9433 was one of the higher producers.  Interestingly, strain CPHL9433 has a 
mutation in gacA, encoding part of the GacAS two-component regulatory system known to 
play a role in regulation of quorum sensing.  It has been reported that gacA knockout mutants 
are impaired in their ability to produce pyocyanin (Kay et al., 2006).  Hence, this strain is 
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able to overcome two mutations predicted to lead to loss of this phenotype.  Other low 
pyocyanin producers, such as C3719, AA43, AA44, 968333S, NH57388A did not have clear 
lasR loss of function mutations.  In strain 968333S there is a mutation that would lead to a 
single amino acid change in LasR (M212 →R).  An analysis of other quorum sensing-related 
genes (las, rhl and pqs genes) was conducted to look for other mutations that might explain 
this phenotype.  In strain C3719, there is a 184 bp deletion in the rhlI gene.  However, 
mutations in the targeted genes were not found in the other low pyocyanin producers. 
 Loss of function mutations in the genes encoding the component part of the MexAB-
OprM efflux pump are also common in CF and bronchiectasis (Winstanley et al., 2016, 
Hilliam et al., 2017).  Such mutations were found in the genomes of 12 of the panel isolates, 
all associated with CF infections.  The genomes of the sequential CF isolates AA2, AA43 and 
AA44 all contain the same frameshift mutation in mexA.  The related strains IST27 (mucoid) 
and IST27N (non-mucoid), contain the same frameshift mutation in oprM. The late CF 
isolate AMT0023-34 contains a premature stop codon in mexB not seen in the related early 
CF isolate AMT0023-30.  The DK2 isolate has a 78 bp deletion in mexB and a frameshift in 
mexA.  mexB mutations were also detected in the genomes of AUS23 and LES431, whilst a 
mexA mutation was also detected in the genome of NH57388A. 
 Another commonly reported CF adaptation is the occurrence of mucoid colonies, 
usually due to mucA mutations leading to over-production of alginate.  We found that nine of 
the panel isolates carry putative loss of function mutations in mucA.  Eight of these isolates 
were isolated from CF patients.  The ninth was 968333S, an isolate from a patient with non-
CF bronchiectasis.  Of the four strains included in this study and reported previously as 
producing the highest levels of alginate (AMT0060-2, CHA, IST27, 968333S) (Cullen et al., 
2015), three carry putative mucA loss of function mutations (AMT0060-2, IST27 and 
968333S; Table 2).  In the fourth, strain CHA, there is a mutation leading to a single amino 
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acid change (Sall et al., 2014). The presence of a mucA mutation in the genome does not 
guarantee that an isolate will have the mucoid phenotype because compensatory mutations 
can occur, leading to reversion to non-mucoid.  IST27N is a spontaneous non-mucoid variant 
of the mucoid strain IST27 (De Soyza et al., 2013).  However, we were unable to detect a 
compensatory mutation that could explain this reversion.  It is clear that not all such 
mutations have been characterised. 
The GacA/GacS two-component regulatory system has been implicated in the switch 
between acute and chronic infection lifestyles and plays a key role in virulence.  Our analysis 
confirmed the presence of the previously reported gacS loss of function deletion mutations in 
the genome of CHA (Sall et al., 2014). We also identified frameshift mutations in the gacS 
genes of strain CPHL9433 (isolated from a tobacco plant) and the related CF isolates 
AMT0060-2, AMT0060-30 and AMT0060-34. 
The analysis confirmed that strain 968333S, a known hypermutator, has an 11 bp 
frame-shifting deletion in the mutS gene, but no other panel strains had putative loss of 
function mutations in any of the DNA mismatch repair genes, mutS, mutL, mutM and uvrD.  
Four isolate genomes contain a nonsense mutation in biofilm dispersal gene rbdA. They were 
isolated from CF (C3719, TBCF10839), the hospital environment (Pr335) and a (keratitis) 
eye infection (39177).  
There were some mutations in genes associated with motility.  As reported previously 
(Jeukens et al., 2014), the genomes of strains LES400 and LES431 have acquired a 
premature stop codon in fleR, implicated in loss of motility. We further observed that the 
non-motile isolate AUS23 has a frame-shift mutation in the fliG gene.  However, we could 
not identify any candidate loss of function mutation in the genome of 968333S, also reported 
to be non-motile. 
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Regions of genome plasticity in the panel strain genomes 
Taking advantage of the phylogenetic distribution, and number, of genomes in the panel, the 
accessory genome of P. aeruginosa was characterized using comparative genomics 
approaches. 2315 regions of genome plasticity (RGPs; regions containing at least two 
consecutive predicted genes that were absent from at least 10% of the genomes) were 
identified (Supplementary Table 1). All but four (25/29) of the curated regions of PAO1 
larger than 2 kb were recovered with good congruence in RGP boundary definition, 
validating the method (Figure 2). The three missed (and one poorly predicted) curated regions 
had been identified by pairwise comparison to various strains and are conserved in over 36 of 
the strains studied here, thereby likely representing regions of lesser plasticity. For example, 
one curated region had been identified by comparison to PA7, a more distantly-related strain 
absent from the panel genomes (Roy et al., 2010, Klockgether et al., 2011).  
The clustering of RGPs by sequence similarity reveals that most regions are found 
uniquely in a few strains (Figure 3A). This is likely due primarily to the high diversity of P. 
aeruginosa genomes and suggests that this genus must be sampled further to better 
characterize the diversity of some P. aeruginosa lineages. To a lesser extent, incomplete 
genome sequencing likely impacts RGP definition and clustering, as small contigs are not 
always accurately placed. As previously observed (Klockgether et al., 2011), RGPs are 
scattered around the genome (Figure 2). GI and prophage predictions overlap respectively 
with 43% and 16% of the RGPs encoding more than 4 genes, suggesting that these regions 
have been acquired horizontally (Figure 3B). Most of the RGPs, including GIs and 
prophages, previously described (Winstanley et al., 2009, Klockgether et al., 2011) were 
identified in the reference genomes of P. aeruginosa PAO1, PA14 and LESB58 
(Supplementary Table 1).  
Downloaded from https://academic.oup.com/femsle/advance-article-abstract/doi/10.1093/femsle/fny120/5035990
by University of Strathclyde user
on 19 June 2018
Hierarchical clustering and neighbour-joining reconstructions, based on the 
presence/absence of each group of RGP in the panel strains (Figure 3B and 3C), clearly 
separates the two major groups of P. aeruginosa shown in Figure 1, and successfully groups 
very close monophyletic strains. Nevertheless, the Robinson-Foulds distance between the 
core genome SNV phylogeny and RGP presence-absence phylogenies is high (42-48). Thus, 
although the presence/absence of groups of RGPs lacks resolution, it still harbours some 
phylogenetic signal. This suggests that, at least at the largest clade grouping level, there may 
be distinct accessory regions, GI and prophage gene pools that each large clade is drawing 
upon. The analysis of additional genomes could improve the resolution of the tree and further 
reveal the association of different mobile gene pools with different clades.  
In addition to the RGPs, we identified the presence of two very large deletions with 
distinct boundaries (2950111 to 3129523 and 2972067 to 3174547 of PA14) in strains 
AMT0023-34 and Mi162_2 isolated from CF and burn patients, respectively. A similar event 
with no mention of a mobile element in this region had previously been observed in a CF 
isolate RN43 with no apparent growth defect (Cramer et al., 2011). Our findings in two 
strains belonging to the two major groups (Figure 1) suggest that this 179 kb genomic region 
close to the terminus of replication (around 3.219 Mb in PA14) is dispensable and prone to 
deletion in P. aeruginosa strains.  
Antimicrobial resistance genes and mutations in the panel strain genomes  
We characterized the resistome of the panel strains using a database approach (Figure 4). 
From the 40 genomes analysed, 37 unique resistomes were identified, thus reinforcing the 
considerable diversity observed in antibiotic susceptibility for these strains (Cullen et al., 
2015). However, the observation that CF strains generally showed resistance to more 
antibiotics than non-CF strains was not as clear when looking at the resistome data. In fact, 
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attempting to relate these results with previously determined antimicrobial susceptibility data 
(Cullen et al., 2015) was difficult. This is likely to be due to the non-specific nature and 
expression level dependence of efflux mechanisms (Blair et al., 2015). Only resistance to 
quinolones (Nakano et al., 1997, Lee et al., 2005) was relatively easy to associate with 
specific gyr variants.  This difficulty has been highlighted previously for P. aeruginosa.  
Jeukens et al. (Jeukens et al., 2017) have demonstrated this by focussing on a limited set of 
strains, including LESB58, which is on the more “resistant” side of the panel, and PAO1, on 
the “susceptible” side. Expression levels of the intrinsic gene ampC appeared more likely to 
underlie differences in beta-lactam resistance (Cabot et al., 2011) than the variant of 
Pseudomonas-derived cephalosporinase (PDC) or AmpC beta-lactamase present.  In addition, 
differences in the resistance to aminoglycosides has been attributed mostly to the regulation 
of efflux mechanisms (Poole, 2005, Garneau-Tsodikova & Labby, 2016). The gyr variant 
found in LESB58 could reasonably account for ciprofloxacin and levofloxacin (quinolones) 
resistance, yet it does not account for quinolone resistance in LES400, for instance. Efflux 
pumps do also have an impact on quinolone resistance in P. aeruginosa (Jalal et al., 2000, 
Lomovskaya et al., 2001, Kriengkauykiat et al., 2005).  
Conclusions  
We have demonstrated that the reference panel of isolates harbours substantial phylogenetic 
diversity, and includes representatives in both of the major P. aeruginosa groups (group 1 
and 2).  It was possible to identify loss of function mutations indicative of adaptation, 
especially amongst isolates associated with chronic respiratory infections, but our study 
further demonstrates the difficulty in relating genomics data to P. aeruginosa isolate 
phenotypes, especially in relation to AMR. These difficulties reflect both the diversity of the 
strains included in the panel, and the complexity of the regulatory networks that control 
virulence and other functions in P. aeruginosa (Balasubramanian et al., 2013). Much of our 
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knowledge to date has relied on close analysis of a limited number of laboratory reference 
strains.  Our findings demonstrate the need to extend beyond this to capture the diversity of 
the species.  Our examination of the accessory genome content indicated that group 1 and 
group 2 isolates also form separate clusters based on mobile gene content. The analysis of 
additional genomes in this diverse genera could improve the resolution of the tree and further 
reveal the degree of association of different mobile gene pools with different 
clades/taxonomic levels, including genes of medical interest, such as those associated with 
AMR. 
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Figure 1. Core genome phylogeny based on 218,520 SNVs. Red dots identify panel strains, 
while black dots identify strains from NCBI. Commonly studied reference strains are 
identified by yellow boxes. The two main groups that define the population structure of P. 
aeruginosa are highlighted in light blue.  Strain PA7, which clusters separately from these 
two groups (and is not in the panel) was included for comparison. 
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Figure 2. Circular genome view, illustrating the distribution and conservation of predicted 
RGPs using the P. aeruginosa PAO1 genome. From the outer to the inner circle: genes on the 
plus and minus strands (grey),  the number of RGPs in the 40 strains bordered by conserved 
genes based on the orthogroups of proteins (red peaks), the number of orthologs of PAO1 
proteins (blue), the predicted RGPs (dark red), curated literature RGPs (purple) and the 
presence of orthologs of PAO1 proteins in the 39 other Pseudomonas panel genomes 
belonging to group 1 (orange) and group 2 (light blue), GC content (green/yellow), and GC 
skew (purple). 
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Figure 3. Conservation of genomic islands (GIs), phages and other Regions of Genome 
Plasticity (RGPs). (A) Conservation of RGPs among the 40 genomes, showing that most 
regions are found uniquely in a few strains. (B) Hierarchical clustering of strains based on the 
presence-absence of RGPs. The two main groups of P. aeruginosa strains are indicated below 
the cladogram in orange (group 1) and blue (group 2). The prediction of RGPs as probable 
phages or other GIs, is indicated in green and salmon, respectively. Other RGPs are shown in 
purple. (C) Neighbour-joining phylogenetic tree, based on a distance matrix of the percentage 
of shared RGP groups, clusters the main groups of P. aeruginosa (group 1; orange, group 2; 
blue labels) similarly to that of the core genome phylogeny shown in Figure 1. 
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Figure 4. Resistome of the panel strains. Gene or variant (*) presence was determined using 
the RGI-CARD (McArthur et al., 2013). AMR genes are grouped by antibiotic family or 
function. Green: perfect match to a gene or variant (*) in the CARD, red: similar to a gene in 
the CARD, according to curated cut-offs, black: no match in the CARD. Genomes are 
ordered based on hierarchical clustering of the resistomes (dendrogram not shown). 
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 Table 1. Summary of strains and genome sequence data. 
Strain Sour
ce 
Thi
s 
stu
dy 
Accession 
number 
Gen
ome 
size 
(bp) 
N50 
(bp) 
Sc
aff 
(n) 
Medi
an 
cover
age 
a
c
s 
ar
o 
g
u
a 
m
ut 
n
u
o 
p
ps 
tr
p 
ML
ST 
                
LESB58 CF N NC_01177
0 
    6 5 1
1 
3 4 2
3 
1 14
6 
LES400 CF N NZ_CP006
982 
    6 5 1
1 
3 4 2
3 
1 14
6 
LES431 CF N NC_02306
6 
    6 5 1
1 
3 4 2
3 
1 14
6 
C3719 CF Y MCMM00
000000 
6192
913 
409
151 31 35 
2
8 5 
1
1 18 4 
1
3 3 
21
7 
DK2 CF N NC_01808
0 
            
AES-1R CF Y MCML000
00000 
6343
337 
414
654 32 27 
1
1 
8
4 
1
1 
3 4 4 7 64
9 
AUS23 
(AUST-
02) 
CF Y MCMN00
000000 6272
404 
485
799 44 57 
2
8 
5 1
1 
5 4 4 7 77
5 
AUS52 CF Y MCMK000
00000 
6209
179 
963
855 23 34 
2
8 
5 5 11 3 1
5 
4
4 
24
2 
                
AA2 CF Y MCMJ000
00000 
6258
177 
371
531 50 20 
1
1 
3 1
1 
3 1 4 6
0 
70
8 
AMT 
0023-
30 
CF Y MCMI000
00000 6471
685 
478
937 31 25 
1
1 
5 6 3 7
4 
1
3 
7 13
94 
AMT 
0023-
34 
CF Y MCMH000
00000 6282
816 
433
349 25 27 
1
1 
5 6 3 7
4 
1
3 
7 13
94 
AMT 
0060-1 
CF Y MCNB000
00000 
7036
907 
260
085 75 79 
1
7 
5 5 4 4 4 3 11
1 
AMT 
0060-2 
CF Y MCNA000
00000 
7037
467 
302
236 75 89 
1
7 
5 5 4 4 4 3 11
1 
AMT 
0060-3 
CF Y MCMZ000
00000 
7033
865 
295
479 70 80 
1
7 
5 5 4 4 4 3 11
1 
                
PAO1 
(ATCC1
5692) 
wou
nd 
N NC_00251
6 
    7 5 1
2 
3 4 1 7 54
9 
UCBPP-
PA14 
burn N NC_00846
3 
    4 4 1
6 
12 1 6 3 25
3 
PAK Non-
CF 
Y MCMY000
00000 
6384
788 
665
433 24 83 
1
1 
5 1
1 
11 4 4 1
4 
69
3 
CHA CF Y MCMG000
00000 
6512
494 
495
272 25 56 
1
4 
5 1
0 
15
5 
4 1
3 
7 19
19 
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IST27 CF Y MCMX000
00000 
6332
447 
574
655 29 94 
4 4 3 - 1 6 - - 
IST27N mut
ant 
Y MCMW00
000000 
6332
479 
612
142 24 77 
4 4 3 - 1 6 - - 
968333
S 
Non-
CF 
Br 
Y MCMV000
00000 6513
472 
395
054 39 79 
1 5 1
1 
3 4 1
0 
3 23
4 
679 urin
e 
Y MCMU000
00000 
6410
839 
371
307 39 76 
1
1 
5 1
1 
11 3 2
7 
7 19
8 
39016 kera
titis 
Y MCLX0000
0000 
6824
311 
235
815 58 25 
3
8 
1
1 
3 13 1 2 4 23
5 
2192 CF N NZ_CH482
384 
           NK 
NH573
88A 
CF Y MCMT000
00000 
6197
427 
415
910 28 63 
2
8 
5 1
1 
11 4 1
2 
3 38
7 
                
1709-
12 
CF Y LZQH0000
0000 
7129
475 
288
354 56 86 
1
7 
5 5 4 4 4 3 11
1 
Mi162 burn Y MCMF000
00000 
6586
986 
198
657 
10
9 22 
1
3 
4 5 5 1
2 
7 1
5 
30
8 
Jpn156
3 
lake 
wat
er 
Y MCMS000
00000 6374
250 
507
716 33 71 
1
6 
5 3
6 
3 8
3 
9
0 
1 87
6 
LMG 
14084 
wat
er 
Y MCMR000
00000 
7007
718 
260
355 70 67 
1
3 
8 9 3 1 6 9 31
6 
Pr335 HE Y MCMQ00
000000 
6679
225 
539
576 45 96 
6 5 6 7 4 6 7 27 
U018a CF Y MCMP000
00000 
6370
823 
352
039 47 81 
1
1 
8 6 11
5 
4 1
3 
1
8 
85
2 
CPHL94
33 
tob. 
plan
t 
Y MCMO00
000000 6421
125 
674
344 38 86 
2
7 
1
3 
9 15
6 
1 7 1
9
2 
19
20 
RP1 CF Y LNBU0000
0000 
6933
541 
141
566 
10
2 17 
6 5 1 1 1 1
2 
1 39
5 
15108/-
1 
ICU Y MCME000
00000 
7108
153 
199
276 92 31 
1
8 
4 5 3 1 1
7 
1
3 
44
6 
57P31P
A 
COP
D 
Y MCLY0000
0000 
6486
503 
426
852 36 46 
2
3 
5 1
1 
7 1 1
2 
7 27
4 
13121/-
1 
ICU Y MCMD000
00000 
6981
334 
227
566 95 24 
2
2 
2
0 
1
1 
3 3 3 7 34
8 
39177 kera
titis 
Y MCMC000
00000 
6682
085 
464
516 53 25 
6 5 1 7 4 6 7 44
9 
KK1 CF Y MCMB000
00000 
6744
864 
454
271 42 26 
2
8 
5 3
6 
3 3 1
3 
7 15
5 
A5803 CAP Y MCMA000
00000 6843
839 
302
775 48 31 
3
2 
8 3 18 1 1
2
3 
1
1
8 
15
67 
TBCF10
839 
CF Y MCLZ0000
0000 
6852
331 
395
296 63 28 
1 5 1
1 
3 4 1
0 
3 23
4 
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Scaff., number of scaffolds; CF, cystic fibrosis; Non-CF, non-CF clinical isolate; Non-CF Br, non-CF 
bronchiectasis; ICU, isolated from a patient in an intensive care unit; HE, hospital environment; tob. 
plant, tobacco plant; COPD, chronic obstructive pulmonary disease; CAP, community acquired 
pneumonia.  NK, not known.  MLST, multilocus sequence type, with individual allele numbers shown 
for the genes acsA (acs), aroE (aro), guaA (gua), mutL (mut), nuoD (nuo), ppsA (pps) and trpE (trp). 
 
Table 2. Summary of loss of function mutations.   
Isolate Mutation Isolate details 
lasR mutants   
LES400 7 bp frame-shift CF (transmissible strain) 
AUS23 Premature stop codon CF (transmissible strain) 
AUS52 Premature stop codon CF (transmissible strain) 
DK2 Gene deleted CF (transmissible strain) 
AMT0023-34 1 bp frame-shift CF (late isolate) 
KK1 Gene deleted CF 
A5803 Premature stop codon Community acquired pneumonia 
Mi162 168 bp frame-shift Burn patient 
CPHL9433 2 bp frame-shift Tobacco plant 
mucA mutants   
AUS23 5 bp frame-shift CF (transmissible strain) 
AUS52 Premature stop codon CF (transmissible strain) 
DK2 1 bp frame-shift CF (transmissible strain) 
AMT0060-1 1 bp frame-shift 
1 bp frame-shift 
CF (late isolate) 
AMT0060-2 1 bp frame-shift CF (late isolate) 
NH57388A 89 bp deletion CF 
IS27 & IS27N 1 bp frame-shift CF 
968333S 7 bp frame-shift Non-CF bronchiectasis 
mexA-mexB-oprM mutants  
LES431 1 bp frame-shift (mexB) CF (transmissible strain) 
AUS23 Premature stop codon (mexB) CF (transmissible strain) 
AUS52 1 bp frame-shift (mexA) CF (transmissible strain) 
DK2 2 bp frame-shift (mexA) 
78 bp deletion (mexB) 
CF (transmissible strain) 
AMT0023-34 Premature stop codon (mexB) CF (late isolate) 
AA2 1 bp frame-shift (mexA) CF  
NH57388A 1 bp frame-shift (mexA) CF 
IS27 & IS27N 2 bp frame-shift (oprM) CF 
mutS mutants   
968333S 11 bp frame-shift Non-CF bronchiectasis 
gacAS mutants   
AMT0060-2 2 bp frame-shift (gacA) CF (late isolate) 
AMT0023-30 2 bp frame-shift (gacA) CF (early isolate) 
AMT0023-34 2 bp frame-shift (gacA) CF (late isolate) 
CPHL9433 37 bp frame-shift (gacA) Tobacco plant 
CHA 148 bp deletion (gacS) CF 
motility mutants   
LES400 & LES431 Premature stop codon (fleR) CF (transmissible strain) 
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AUS23 1 bp frame-shift (fliG) CF (transmissible strain) 
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